“Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement”, J of Skin, vol. 10, no. 2, p. s726, Mar. 2026, doi: 10.25251/mjfdzc48.